Literature DB >> 25266085

Hepatitis A hospitalizations in the United States, 2002-2011.

Melissa G Collier1, Xin Tong, Fujie Xu.   

Abstract

UNLABELLED: Hepatitis A illness severity increases with age. One indicator of hepatitis A illness severity is whether persons are hospitalized. We describe changes in primary hepatitis A hospitalization rates in the United States from 2002-2011, including changes in demographics, secondary discharge diagnoses, and factors affecting hospitalization duration. We describe changes from 2002-2011 among U.S. residents hospitalized with a principal hepatitis A diagnosis and accompanying secondary diagnoses using ICD-9 codes from the National Inpatient Survey discharge data. We calculated rates of hospitalizations with hepatitis A as the principal discharge diagnosis and rates of secondary discharge diagnoses. Using multiple regression, we assessed the effect of secondary diagnoses on hospitalization length of stay for five time intervals: 2002-2003, 2004-2005, 2006-2007, 2008-2009, and 2010-2011. Rates of hospitalization for hepatitis A as a principal diagnosis decreased from 0.72/100,000 to 0.29/100,000 (P < 0.0001) and mean age of those hospitalized increased from 37.6 years to 45.5 years (P < 0.0001) during 2002-2011. The percentage of hepatitis A hospitalizations covered by Medicare increased from 12.4% to 22.7% (P < 0.0001). Secondary comorbid discharge diagnoses increased, including liver disease, hypertension, ischemic heart disease, disorders of lipid metabolism, and chronic kidney disease. No changes in length-of-stay or in-hospital deaths from hepatitis A over time were found, but persons with liver disease were hospitalized longer.
CONCLUSION: Hospitalization rates for hepatitis A illness have declined significantly from 2002-2011, but the characteristics of the hospitalized population also changed. Persons hospitalized for hepatitis A in recent years are older and more likely to have liver diseases and other comorbid medical conditions. Hepatitis A disease and resulting hospitalizations could be prevented through adult vaccination.
© 2014 Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2015        PMID: 25266085     DOI: 10.1002/hep.27537

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

1.  Physician Knowledge and Attitudes About Hepatitis A and Current Practices Regarding Hepatitis A Vaccination Delivery.

Authors:  Noele P Nelson; Mandy A Allison; Megan C Lindley; Michaela Brtnikova; Lori A Crane; Brenda L Beaty; Laura P Hurley; Allison Kempe
Journal:  Acad Pediatr       Date:  2017-01-09       Impact factor: 3.107

2.  Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

Authors:  Eleanor E Friedman; Hazel D Dean; Wayne A Duffus
Journal:  Public Health Rep       Date:  2018-06-06       Impact factor: 2.792

3.  Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans.

Authors:  Jason W Wen; Michael A Kohn; Robert Wong; Ma Somsouk; Mandana Khalili; Jacquelyn Maher; Michele M Tana
Journal:  Am J Gastroenterol       Date:  2018-01-30       Impact factor: 10.864

4.  Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children.

Authors:  Abigail Hankin-Wei; David B Rein; Alfonso Hernandez-Romieu; Mallory J Kennedy; Lisa Bulkow; Eli Rosenberg; Monica Trigg; Noele P Nelson
Journal:  Vaccine       Date:  2016-06-27       Impact factor: 3.641

Review 5.  Epidemiology and Transmission of Hepatitis A Virus and Hepatitis E Virus Infections in the United States.

Authors:  Megan G Hofmeister; Monique A Foster; Eyasu H Teshale
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

6.  Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.

Authors:  Noele P Nelson; Mark K Weng; Megan G Hofmeister; Kelly L Moore; Mona Doshani; Saleem Kamili; Alaya Koneru; Penina Haber; Liesl Hagan; José R Romero; Sarah Schillie; Aaron M Harris
Journal:  MMWR Recomm Rep       Date:  2020-07-03

Review 7.  Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus.

Authors:  Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Masato Nakamura; Xia Jiang; Yuki Haga; Reina Sasaki; Osamu Yokosuka
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

8.  CXCL10 is produced in hepatitis A virus-infected cells in an IRF3-dependent but IFN-independent manner.

Authors:  Pil Soo Sung; Seon-Hui Hong; Jeewon Lee; Su-Hyung Park; Seung Kew Yoon; Woo Jin Chung; Eui-Cheol Shin
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

Review 9.  Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review.

Authors:  Anke L Stuurman; Cinzia Marano; Eveline M Bunge; Laurence De Moerlooze; Daniel Shouval
Journal:  Hum Vaccin Immunother       Date:  2016-10-27       Impact factor: 3.452

10.  Comparative Analysis of Liver Injury-Associated Cytokines in Acute Hepatitis A and B.

Authors:  So Youn Shin; Sook-Hyang Jeong; Pil Soo Sung; Jino Lee; Hyung Joon Kim; Hyun Woong Lee; Eui-Cheol Shin
Journal:  Yonsei Med J       Date:  2016-05       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.